Solara Active Pharma Sciences – Pure Play API

There are multiple things that are not going well for this stock apart from the timing:

1. They changed the business model when their primary product ibuprofen was coming under pressure. The quarterly revenue dropped by 75%
2. The top management either got fired or resigned and the promoters never explained it adequately.
3. They initiated the Merger and then dropped the plan.
4. This caused the market to tumble, further deteriorating their debt-to-equity ratio.

P.S.: I am still invested as I do hope that mgmt experience will come in handy to ensure that they are able to get back their mojo.